TuesdayMar 20, 2018 11:31 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Filing of New Patent Application

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has filed a new patent application with the United States Patent and Trademark Office for the use of its DehydraTECH™ technology to improve the speed and quantity of absorption of active pharmaceutical ingredients through the skin. This update comes on the heels of Lexaria’s recently detailed successful laboratory evaluation of DehydraTECH™ in the transdermal delivery of cannabidiol. Per company data, the platform demonstrated as much as a 225 percent increase in CBD permeability when compared to control formulations featuring leading commercial penetration enhancers, as…

Continue Reading

MondayMar 19, 2018 9:25 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Inks Definitive Amalgamation Agreement to Acquire Late Stage ACMPR Applicant

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning said that along with its wholly-owned subsidiary, Arbutus Brands Inc., it has entered into a definitive amalgamation agreement with International Tungsten Inc. ("ITI"). Per the terms of the agreement, Arbutus Brands will merge with ITI and the combined company will remain a wholly-owned subsidiary of Choom operating under the name of Arbutus Brands. All issued and outstanding securities of ITI will be exchanged for securities of Choom. Additionally, ITI has entered into an agreement to acquire all of the issued and outstanding securities of an applicant…

Continue Reading

MondayMar 19, 2018 9:03 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Named to the CSE25 Index

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced that, effective March 16, 2018, the company has been named to the CSE25 Index, a composite of the 25 largest companies, as measured by market capitalization, listed on the Canadian Securities Exchange. “With an impressive pipeline of bio-cannabis products, a strong intellectual property portfolio of formulation and delivery technologies, and the expected addition of ACMPR licensed Agro-Biotech, we are proud to be recognized as leaders on the Canadian Securities Exchange through our inclusion in the CSE25 Index,” Dr. Patrick Frankham, CEO of Pivot, stated in the news…

Continue Reading

FridayMar 16, 2018 9:58 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Incorporates Australian Subsidiary

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the incorporation of its first Australian wholly owned subsidiary, PreveCeutical (Australia) Pty Ltd. Per the update, the company’s decision to incorporate a subsidiary in Australia was influenced by the nation’s strong foundation of academic and clinical research, as well as the government’s commitment to supporting innovation through a range of programs and incentives. “Establishing a business presence in Australia will allow PreveCeutical to better access expertise and partnerships for its drug development programs,” Dr. Maher Khaled, PreveCeutical’s director of international operations, stated in the news…

Continue Reading

FridayMar 16, 2018 9:29 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Announces Resignation of Ken Clement

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a pharmaceutical-grade cannabis company with production and sales licenses from Health Canada, this morning announced that its founder and director, Ken Clement, has resigned from its board of directors. “On behalf of the Board, we thank Ken for his vision in starting the company and growing it from a start-up organization into a well-funded publicly-traded licensed producer with a bright future,” Paul Lucas, chairman of ABcann, stated in the news release. “We wish Ken well in his future endeavours.” To view the full press release, visit http://cnw.fm/riDc3 About ABcann Global Corp. ABcann holds…

Continue Reading

TuesdayMar 13, 2018 10:57 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Positive Results from Skin Absorption Study

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning said that it has completed the first study evaluating DehydraTECH™ used in a topical cream formulation for absorption of cannabidiol ("CBD") through human skin. Compared to control formulations, significant increases in the speed and quantity of CBD absorption through skin were proven in the study. Several factors were measured during the study at multiple testing intervals over a 48-hour duration, including the time required to detect CBD skin penetration and quantity as well as the peak amounts of CBD absorbed.  Lexaria's DehydraTECH-enabled topical formulation without the addition of either of the commercial…

Continue Reading

TuesdayMar 13, 2018 9:55 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Grant of Australian Cannabis Importation Permits

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), alongside Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (FSE: 21P), this morning announced the grant of three permits by the Australian government’s Department of Health for the importation of cannabis into the country for research purposes. Per the news release, cannabis related to these permits will be shipped from Canada by Aurora for use in PreveCeutical’s soluble gel (“Sol-gel”) drug delivery research program, which is being conducted by the company’s research partner, UniQuest Pty Inc., and led by PreveCeutical’s chief research officer, Dr. Harendra Parekh. “We are extremely…

Continue Reading

MondayMar 12, 2018 9:29 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Preparing to File Dealer’s License Application for Agro-Biotech Inc.

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced that it has retained Cannabis Compliance Inc. (“CCI”) in order to submit an application, on behalf of Agro-Biotech Inc., to Health Canada for a dealer’s license under the Controlled Drugs and Substances Act and the Narcotic Control Regulations enacted thereunder. This morning’s update comes on the heels of a February 22 announcement of Pivot’s entry into a letter of intent for the proposed acquisition of Agro-Biotech. “The addition of a Dealer's License for the Agro-Biotech facility will allow the Company to exercise complete control of our finished…

Continue Reading

ThursdayMar 08, 2018 9:56 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Engages VIRTUE to Serve as Agency of Record

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has retained VIRTUE as its agency-of-record. VIRTUE, a creative agency powered by VICE Media, will develop a full rebrand and create sub-brands targeting the medical and adult-use cannabis markets. The agency will also assist the company with an integrated launch strategy for its new brands. “VIRTUE is an award-winning marketing agency with an unwavering commitment to bold ideas. They are the ideal partners to help us to transform the company’s brand and convey the purpose behind our current medical and upcoming adult-use cannabis businesses,” ABcann chief marketing officer Sung…

Continue Reading

WednesdayMar 07, 2018 11:14 am

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Closes $1.5M Private Placement

Hemp cultivation company Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) this morning announced the closing of a non-brokered private placement consisting of 12.5 million units, sold at a price of $0.12 per unit, to raise aggregate gross proceeds of $1.5 million. Each unit consists of one common share of Global Hemp Group and one common share purchase warrant redeemable at a price of $0.15 per common share for a period of five years from closing. Insiders of the company subscribed for an amount of $371,542, or 24.8 percent of the total placement. Per the update, proceeds from…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977